A rare soft-tissue sarcoma
LMS belongs to the soft-tissue sarcoma family. Its rarity is one reason pathology review, treatment planning, and clinical-trial decisions benefit from clinicians who routinely manage sarcoma rather than seeing a case once every few years.
Read the NCI LMS overview ↗